Stanford University: Hemorrhage trials
The registry lists 10 Hemorrhage studies with Stanford University as lead sponsor. 2 are open to participants now and 4 have results posted.
Early Phase 1 1Phase 1 1Phase 2 2Phase 3 2No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Decreasing Hemorrhage Risk in Children With Alagille SyndromeEnrolling by invitationNCT05846854Not applicable
- Oxytocin Pharmacokinetics and PharmacodynamicsRecruitingNCT05488457Phase 2
- Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean DeliveryCompletedNCT05027048Phase 3Results posted
- Calcium Chloride for Prevention of Uterine Atony During CesareanCompletedNCT03867383Phase 1/2Results posted
- Cerebral Oxygenation and Autoregulation in Preterm InfantsCompletedNCT02147769Results posted
- Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.CompletedNCT01932060Phase 3Results posted
- Pharmacokinetic Equivalence of Calcium Gluconate and Calcium Chloride in ParturientsCompletedNCT05973747Early Phase 1
- Non-Invasive Measurement of Hemoglobin (Using Pulse Co-Oximetry) in Patients Undergoing Elective Cesarean DeliveryCompletedNCT01108471
- Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.CompletedNCT00767832
- Diagnostic Utility of MRI in Intracerebral HemorrhageCompletedNCT00363662